5.25
price up icon3.55%   0.18
after-market Dopo l'orario di chiusura: 5.25
loading
Precedente Chiudi:
$5.07
Aprire:
$5.07
Volume 24 ore:
240.53K
Relative Volume:
5.38
Capitalizzazione di mercato:
$427.92M
Reddito:
$163.13M
Utile/perdita netta:
$-34.75M
Rapporto P/E:
-10.19
EPS:
-0.5152
Flusso di cassa netto:
$-231.66M
1 W Prestazione:
+10.76%
1M Prestazione:
+21.53%
6M Prestazione:
-27.08%
1 anno Prestazione:
-35.58%
Intervallo 1D:
Value
$4.96
$5.3397
Intervallo di 1 settimana:
Value
$4.71
$5.3397
Portata 52W:
Value
$3.62
$9.50

Valneva Se Adr Stock (VALN) Company Profile

Name
Nome
Valneva Se Adr
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
676
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
VALN's Discussions on Twitter

Confronta VALN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
VALN
Valneva Se Adr
5.25 427.92M 163.13M -34.75M -231.66M -0.5152
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
438.40 113.67B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
683.08 74.97B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
665.68 40.50B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
277.16 35.95B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
120.88 29.63B 3.30B -501.07M 1.03B -2.1146

Valneva Se Adr Stock (VALN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2022-08-03 Iniziato H.C. Wainwright Buy

Valneva Se Adr Borsa (VALN) Ultime notizie

pulisher
Jan 21, 2025

Favorable VLA1553-321 Phase 3 Study Results Boost VALN Stock - Yahoo Finance

Jan 21, 2025
pulisher
Jan 20, 2025

Valneva Reports High Sustained Immune Response in Adolescents One Year After Single Vaccination with its Chikungunya Vaccine - GlobeNewswire Inc.

Jan 20, 2025
pulisher
Dec 05, 2024

VALNEVA - GlobeNewswire Inc.

Dec 05, 2024
pulisher
Nov 28, 2024

Chikungunya Vaccine Label Extension Call Likely to Support VALN Stock - Yahoo Finance

Nov 28, 2024
pulisher
Nov 08, 2024

Valneva SE earnings missed by $0.02, revenue fell short of estimates - Investing.com

Nov 08, 2024
pulisher
Nov 06, 2024

Valneva SE (VALN) Q3 2024 Earnings Report Preview: What to Look For - Yahoo Finance

Nov 06, 2024
pulisher
Oct 12, 2024

H.C. Wainwright maintains Buy rating on Valneva SE stock, lowers price target By Investing.com - Investing.com South Africa

Oct 12, 2024
pulisher
Oct 11, 2024

H.C. Wainwright maintains Buy rating on Valneva SE stock, lowers price target - Investing.com

Oct 11, 2024
pulisher
Oct 04, 2024

Valneva SE Declaration of shares and voting rights - GlobeNewswire Inc.

Oct 04, 2024
pulisher
Sep 25, 2024

H.C. Wainwright updates Valneva SE outlook following capital raise, reiterates Buy - Investing.com

Sep 25, 2024
pulisher
Sep 25, 2024

H.C. Wainwright updates Valneva SE outlook following capital raise, reiterates Buy By Investing.com - Investing.com South Africa

Sep 25, 2024
pulisher
Sep 25, 2024

In-Depth Examination Of 6 Analyst Recommendations For Valneva - Benzinga

Sep 25, 2024
pulisher
Sep 04, 2024

Valneva shares hold strong with buy rating on Lyme vaccine data - Investing.com

Sep 04, 2024
pulisher
Sep 04, 2024

Wall Street Analysts Predict a 150.41% Upside in Valneva (VALN): Here's What You Should Know - MSN

Sep 04, 2024
pulisher
Sep 03, 2024

Favorable VLA15 Phase 2 Study Results Might Boost VALN Stock - Zacks Investment Research

Sep 03, 2024
pulisher
Aug 15, 2024

How Much Upside is Left in Valneva (VALN)? Wall Street Analysts Think 135.3% - Yahoo Finance

Aug 15, 2024
pulisher
Jul 26, 2024

Can Valneva (VALN) Climb 149.04% to Reach the Level Wall Street Analysts Expect? - Zacks Investment Research

Jul 26, 2024
pulisher
Jul 08, 2024

Valneva (VALN) Gets EC's Approval on Chikungunya Vaccine - Zacks Investment Research

Jul 08, 2024
pulisher
Jun 24, 2024

Valneva's (VALN) CHIKV Vaccine Gets Health Canada's Approval - Yahoo Finance

Jun 24, 2024
pulisher
Mar 21, 2024

Earnings call: Valneva reports robust growth and strategic R&D focus By Investing.com - Investing.com South Africa

Mar 21, 2024
pulisher
May 30, 2023

Valneva (VALN) Stock Down 53% in the Past Year: Here's Why - Nasdaq

May 30, 2023
pulisher
Jan 16, 2023

Valneva (VALN) Stock Down 61.5% in the Past Year: Here's Why - Yahoo Finance

Jan 16, 2023
pulisher
Jun 14, 2022

Valneva (VALN) Down on its COVID-19 Vaccine Update in Europe - Zacks Investment Research

Jun 14, 2022
pulisher
May 17, 2022

Valneva (VALN) Down as EU Considers Ending COVID-Vaccine Deal - Yahoo Finance

May 17, 2022
pulisher
Apr 03, 2022

5 Top Health Care Stocks To Watch In The Stock Market Today - Stock Market

Apr 03, 2022
pulisher
Nov 24, 2021

Valneva Stock Is Jumping on European Vaccine Supply Deal - Barron's

Nov 24, 2021
pulisher
Nov 10, 2021

Valneva Stock Surges After EU Vaccine Deal - Investing.com

Nov 10, 2021
pulisher
Oct 27, 2021

Valneva Shares Off 12% On Share Offering News By Investing.com - Investing.com UK

Oct 27, 2021
pulisher
Oct 19, 2021

Valneva (VALN) Reports Positive Data From COVID Vaccine Study - Nasdaq

Oct 19, 2021
pulisher
Sep 13, 2021

Valneva Stock Plunges as U.K. Drops Covid-19 Vaccine Deal - Barron's

Sep 13, 2021
pulisher
May 07, 2021

EU set to sign off new Pfizer vaccine contract as soon as Friday - Luxembourg Times

May 07, 2021
pulisher
Jul 08, 2019

Shareholder Structure - Valneva

Jul 08, 2019
pulisher
Jul 08, 2019

Stock Price - Valneva

Jul 08, 2019

Valneva Se Adr Azioni (VALN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$352.30
price down icon 5.49%
$41.04
price up icon 0.79%
$22.36
price up icon 3.33%
$5.41
price up icon 3.84%
biotechnology ONC
$226.89
price up icon 0.08%
$120.88
price down icon 0.23%
Capitalizzazione:     |  Volume (24 ore):